LID.L Share News (LID)

LiDCO Expects To Swing To Pretax Profit In Full Year, As Expected

LONDON (Alliance News) - LiDCO Group PLC Wednesday said it expects pretax profit for the year ended January 31 to be in line with expectations, compared with a loss of GBP260,000 a year earlier. In a trading update ahead of its full-year results, the cardiovascular monitoring company said r

UK MORNING BRIEFING: Telecity Drops 13% As Market Awaits BOE

LONDON (Alliance News) - Shares have opened mostly flat Wednesday, as the market awaits the Bank of England's Quarterly Inflation Report at 1030 GMT.

Telecity is holding back the FTSE 250. The data-centre provider is down 13% after announcing higher 2013 profit and

LiDCO cash-flow positive as losses come down in first half

Surgical blood monitoring group LiDCO said it expected to be cash generative and profitable in the full year after slashing losses in the first half. Chief Executive Officer Terry O'Brien said the company had seen significant sales growth in the UK and export markets in the six months to end-July

LiDCO Granted Graphical User Interface Patent By US Patent Office

LiDCO receives approval from FDA

LiDCO, a cardiovascular monitoring company, said Wednesday that the US Food and Drug Administration (FDA) has cleared its CNSystems' continuous non-invasive blood pressure monitoring module for sale. The software enables the connection of modules to the LiDCOrapid cardiac output monitor allowing i

LiDCo Says Blood Pressure System Using Its Montior Gets FDA Clearance

STOCKS NEWS EUROPE-UK small caps outperform wider market

UK small caps and junior-listed AIM shares trade flat and up 0.1 percent respectively, outperforming the wider market where the mid-caps shed 0.6 percent and the blue chips trade 0.2 percent weaker. AIM-listed cardiovascular monitoring firm LiDCO Group advances almost 5 percent after the c

STOCKS NEWS EUROPE-UK small caps fall less than broader market

The FTSE small-cap index and the junior FTSE Alternative Investment Market (AIM) all-share index both end 1.3 percent lower, outperforming a 1.8 percent fall for the mid caps and a 2.1 percent drop on the blue chips. Shares in VPhase fall 44 percent to 0.26 pence as the AIM-listed energy ef

LiDCO surges on positive clinical trials

AIM-listed cardiovascular monitoring company LiDCO Group, has revealed that its LiDCOrapid blood monitoring system has been used successfully to monitor patients having major liver surgery. The hemodynamic system monitored cardiac output and guided intravenous fluid therapy in a randomised clinica

LiDCO drives US expansion

Cardiovascular monitoring company LiDCO confirmed that it has acquired the existing LiDCOrapid customer base from Covidien, its previous US distribution partner, as it beefs up commercial opportunities in the US. After an initial integration and switch-over period the group expects associated rev

Small caps round-up: Infrastructure India, SkyePharma, LiDCO Group

Infrastructure India, an AIM-listed investment group, pleased its investors with a 50.2 per cent leap in its net asset value (NAV) to 207.3m pounds over the year ended March. The value of the company's investments rose 94.9 per cent to 216.7m pounds, while the NAV per share climbed from 92p to 95p.

LiDCO posts maiden profit

LiDCO, the blood movement monitoring company, announced its maiden post-tax profit although phasing issues with a major customer meant the numbers were not as impressive as the market had been expecting. The company made a loss of £45,000 before tax in the year to January 31st, versus a loss of £49

Thursday tips round-up: BATs, CSR, Lidco...

British American Tobacco, the world's second-biggest maker of cigarettes, yesterday delivered a smoking set of results for the first nine months of this year, writes the Investment Column in the Independent. The volume of cigarettes sold by the group slipped by 0.4 per cent but BAT's ability to push

LiDCO's sales to grow 18%

Cardiovascular monitoring company LiDCO expects revenue in the six months ended 31 July to be 18% ahead of the first half of 2010. The firm predicts sales to be at least £3.1m, compared to the £2.66m reported the year before, while losses are said to have been "significantly reduced". Pre-tax losse

Premier Farnell director buys after shares wither

Premier Farnell non-executive director Paul Withers has taken advantage of a recent weak spell in the electrical components and industrial products supplier's share price, spending nearly £55,000. He took 30,000 shares at 183p a go, and now has 70,000. Shares in Premier Farnell took a dive earlier